Showing results (11-20 of 122) with videos related to

Sort By:
Pageof 13
European Urology|August 31, 2020
Is it Time to Consider Eliminating Surgery from the Treatment of Locally Advanced Bladder Cancer?Andrea Necchi, Laura Marandino, Daniele Raggi, et al.
Therapeutic Advances in Urology|July 11, 2015
Clinical experience with temsirolimus in the treatment of advanced renal cell carcinomaElisa Zanardi, Elena Verzoni, Paolo Grassi, et al.
Critical Reviews in Oncology/Hematology|February 5, 2021
Outcome of patients with advanced upper tract urothelial carcinoma treated with immune checkpoint inhibitors: A systematic review and meta-analysisMelissa Bersanelli, Sebastiano Buti, Patrizia Giannatempo, et al.
Cancer|May 13, 2022
Adjuvant immunotherapy in patients with high-risk muscle-invasive urothelial carcinoma: The potential impact of informative censoringAlberto Martini, Menggang Yu, Daniele Raggi, et al.
Clinical Genitourinary Cancer|November 14, 2022
A Systematic Review of Published Clinical Trials in the Systemic Treatment of Adrenocortical Carcinoma: An Initiative Led on Behalf of the Global Society of Rare Genitourinary TumorsTiago Costa de Padua, Laura Marandino, Daniele Raggi, et al.
European Urology|October 27, 2015
The Impact of Adding Taxanes to Gemcitabine and Platinum Chemotherapy for the First-Line Therapy of Advanced or Metastatic Urothelial Cancer: A Systematic Review and Meta-analysisPatrizia Giannatempo, Gregory R Pond, Guru Sonpavde, et al.
Current Opinion in Urology|November 16, 2021
Von Hippel-Lindau disease-associated renal cell carcinoma: a call to actionAlessandro Larcher, Isaline Rowe, Federico Belladelli, et al.
Clinical Genitourinary Cancer|September 13, 2015
Panitumumab Treatment for Advanced Penile Squamous Cell Carcinoma When Surgery and Chemotherapy Have FailedAndrea Necchi, Patrizia Giannatempo, Salvatore Lo Vullo, et al.
European Urology Open Science|May 14, 2023
Contextualizing Olaparib and Abiraterone in the Current Treatment Landscape for Metastatic Castration-resistant Prostate CancerGiuseppe Fallara, Daniele Robesti, Daniele Raggi, et al.
European Urology Oncology|August 28, 2020
Neoadjuvant Chemotherapy or Immunotherapy for Clinical T2N0 Muscle-invasive Bladder Cancer: Time to Change the Paradigm?Filippo Pederzoli, Marco Bandini, Laura Marandino, et al.
Pageof 13